Literature DB >> 10753956

Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter.

H Homma1, H Kurachi, Y Nishio, T Takeda, T Yamamoto, K Adachi, K Morishige, M Ohmichi, Y Matsuzawa, Y Murata.   

Abstract

Estrogen exerts a variety of effects not only on female reproductive organs but also on nonreproductive organs, including adipose tissue. Estrogen inhibits obesity triggered by ovariectomy in rodents. We studied the mechanism underlying this estrogen-dependent inhibition of obesity. Estrogen markedly decreased the amounts of fat accumulation and lipoprotein lipase (LPL) mRNA as well as triglyceride accumulation in genetically manipulated 3T3-L1 adipocytes stably expressing the estrogen receptor (ER). A pLPL(1980)-CAT construct, along with an ER expression vector, was introduced into differentiated 3T3-L1 cells, and CAT activities were determined. ER, mostly ligand-dependently, inhibited the basal LPL promoter activity by 7-fold. We searched the LPL promoter for an estrogen-responsive suppressive element by employing a set of 5'-deletion mutants of the pLPL-CAT reporter. Although there was no classical estrogen response element, it was demonstrated that an AP-1-like TGAATTC sequence located at (-1856/-1850) was responsible for the suppression of the LPL gene transcription by estrogen. An electrophoretic mobility shift assay probed with the TGAATTC sequence demonstrated formation of a specific DNA-nuclear protein complex. Interestingly, this complex was not affected by the addition of any antibodies against ER, c-Jun, c-Fos, JunB, or JunD. Because this TGAATTC element responded to phorbol ester and overexpression of CREB-binding protein abrogated the suppressive effect of estrogen on the LPL promoter, we conclude that a unique protein that is related to the AP-1 transcription factor families may be involved in the complex that binds to the TGAATTC element.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10753956     DOI: 10.1074/jbc.275.15.11404

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Hormone replacement therapy for prevention of coronary heart disease: current evidence.

Authors:  P S Khurana; C Khurana; J Hsia
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

2.  Down-regulation of transcription factor peroxisome proliferator-activated receptor in programmed hepatic lipid dysregulation and inflammation in intrauterine growth-restricted offspring.

Authors:  Thomas R Magee; Guang Han; Bindu Cherian; Omid Khorram; Michael G Ross; Mina Desai
Journal:  Am J Obstet Gynecol       Date:  2008-07-29       Impact factor: 8.661

3.  Estrogen sulfotransferase inhibits adipocyte differentiation.

Authors:  Taira Wada; Chibueze A Ihunnah; Jie Gao; Xiaojuan Chai; Su Zeng; Brian J Philips; J Peter Rubin; Kacey G Marra; Wen Xie
Journal:  Mol Endocrinol       Date:  2011-08-04

4.  Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.

Authors:  Jun Ho Kim; Matthew S Meyers; Saja S Khuder; Simon L Abdallah; Harrison T Muturi; Lucia Russo; Chandra R Tate; Andrea L Hevener; Sonia M Najjar; Corinne Leloup; Franck Mauvais-Jarvis
Journal:  Mol Metab       Date:  2014-01-09       Impact factor: 7.422

5.  Maternal Serum Lipid, Estradiol, and Progesterone Levels in Pregnancy, and the Impact of Placental and Hepatic Pathologies.

Authors:  U Pecks; W Rath; N Kleine-Eggebrecht; N Maass; F Voigt; T W Goecke; M G Mohaupt; G Escher
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

Review 6.  The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity.

Authors:  Frederick S Vom Saal; Susan C Nagel; Benjamin L Coe; Brittany M Angle; Julia A Taylor
Journal:  Mol Cell Endocrinol       Date:  2012-01-10       Impact factor: 4.102

7.  Changes in body composition and mRNA expression of ghrelin and lipoprotein lipase in rats treated with leuprolide acetate, a GnRH agonist.

Authors:  Carlos Olvera-Sandoval; Gabriel Betanzos-Cabrera; Rafael Casillas-Peñuelas; J Luis Quintanar
Journal:  Exp Ther Med       Date:  2017-10-23       Impact factor: 2.447

Review 8.  Estrogens and Body Weight Regulation in Men.

Authors:  Katya B Rubinow
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 9.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

Review 10.  G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis.

Authors:  Haifei Shi; Shiva Priya Dharshan Senthil Kumar; Xian Liu
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.